Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism AR antagonists(Androgen Receptor antagonists), PELP1 inhibitors(proline, glutamate and leucine rich protein 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Preclinical | US | 28 May 2013 |